The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 21, 2014

Filed:

Mar. 16, 2011
Applicants:

Joffre B. Baker, Montara, CA (US);

John L. Bryant, Allison Park, PA (US);

Soonmyung Paik, Pittsburgh, PA (US);

Steven Shak, Hillsborough, CA (US);

Inventors:

Joffre B. Baker, Montara, CA (US);

John L. Bryant, Allison Park, PA (US);

Soonmyung Paik, Pittsburgh, PA (US);

Steven Shak, Hillsborough, CA (US);

Assignees:

Genomic Health, Inc., Redwood City, CA (US);

NSABP Foundation, Inc., Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06F 19/24 (2011.01); C12Q 1/68 (2006.01); G06F 19/18 (2011.01); G06F 19/20 (2011.01);
U.S. Cl.
CPC ...
G06F 19/18 (2013.01); C12Q 1/6886 (2013.01); G06F 19/20 (2013.01);
Abstract

The present invention provides gene expression information useful for predicting whether a cancer patient is likely to have a beneficial response to treatment with chemotherapy, comprising measuring, in a biological sample comprising a breast tumor sample obtained from the patient, the expression levels of gene subsets to obtain a risk score associated with a likelihood of a beneficial response to chemotherapy, wherein the score comprises at least one of the following variables: (i) Recurrence Score, (ii) ESRI Group Score; (iii) Invasion Group Score; (iv) Proliferation Group Score; and (v) the expression level of the RNA transcript of at least one of MYBL2 and SCUBE2, or the corresponding expression product. The invention further comprises a molecular assay-based algorithm to calculate the likelihood that the patient will have a beneficial response to chemotherapy based on the risk score.


Find Patent Forward Citations

Loading…